EMA proposes quality guidelines for synthetic peptides and oligonucleotides
Regulatory NewsGareth Macdonald
Biologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)EuropePharmaceuticalsProduct LifecycleRegulatory NewsGareth MacdonaldBiologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)EuropePharmaceuticalsProduct Lifecycle